BPO v. AstraZeneca Pharmaceuticals, Supreme Administrative Court (Върховен Административен Съд), 24 July 2009

search-result-placeholder.jpg

The Bulgarian Patent Office (BPO) revoked patent BG 61365 and published an announcement of the revocation in its official bulletin. The revocation was appealed by AstraZeneca Pharmaceuticals LR. The Court held the decision of the BPO invalid and annulled it as the decision was not in written form and the mere publication in the official bulletin, being only a declarative action, was not sufficient to imply that a valid decision had been adopted.

The full summary of this case has been published on Kluwer IP Law.

Comments (0)
Your email address will not be published.
Leave a Comment
Your email address will not be published.
Clear all
Become a contributor!
Interested in contributing? Submit your proposal for a blog post now and become a part of our legal community! Contact Editorial Guidelines
Image
AI Assistant on Kluwer IP Law's Manual IP
Image
Whitepaper

Book Ad List

Books
book1
Vissers Annotated European Patent Convention 2024 Edition
Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge
€105.00
AIPPI
Experimental Use and Bolar Exemptions
David Gilat, Charles A. Boulakia, Daphné Derouane & Ralph Nack
€190.00
book2
Annotated PCT
Malte Köllner
€160.00